DYAI
Price
$0.91
Change
-$0.02 (-2.15%)
Updated
Aug 28 closing price
Capitalization
32.84M
68 days until earnings call
QSI
Price
$1.15
Change
-$0.01 (-0.86%)
Updated
Aug 28 closing price
Capitalization
232.87M
68 days until earnings call
Interact to see
Advertisement

DYAI vs QSI

Header iconDYAI vs QSI Comparison
Open Charts DYAI vs QSIBanner chart's image
Dyadic International
Price$0.91
Change-$0.02 (-2.15%)
Volume$16.45K
Capitalization32.84M
Quantum-Si
Price$1.15
Change-$0.01 (-0.86%)
Volume$4.26M
Capitalization232.87M
DYAI vs QSI Comparison Chart in %
Loading...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYAI vs. QSI commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYAI is a Buy and QSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (DYAI: $0.91 vs. QSI: $1.15)
Brand notoriety: DYAI and QSI are both not notable
DYAI represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: DYAI: 10% vs. QSI: 54%
Market capitalization -- DYAI: $32.84M vs. QSI: $232.87M
DYAI [@Biotechnology] is valued at $32.84M. QSI’s [@Medical/Nursing Services] market capitalization is $232.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYAI’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • DYAI’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than DYAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYAI’s TA Score shows that 5 TA indicator(s) are bullish while QSI’s TA Score has 5 bullish TA indicator(s).

  • DYAI’s TA Score: 5 bullish, 5 bearish.
  • QSI’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, DYAI is a better buy in the short-term than QSI.

Price Growth

DYAI (@Biotechnology) experienced а +16.18% price change this week, while QSI (@Medical/Nursing Services) price change was +3.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.48%. For the same industry, the average monthly price growth was +6.46%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

DYAI is expected to report earnings on Nov 05, 2025.

QSI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (+0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QSI($233M) has a higher market cap than DYAI($32.8M). DYAI YTD gains are higher at: -48.149 vs. QSI (-57.407). DYAI has higher annual earnings (EBITDA): -5.09M vs. QSI (-106.38M). QSI has more cash in the bank: 214M vs. DYAI (4.98M). DYAI has less debt than QSI: DYAI (5.06M) vs QSI (11.1M). DYAI (3.42M) and QSI (3.41M) have equivalent revenues.
DYAIQSIDYAI / QSI
Capitalization32.8M233M14%
EBITDA-5.09M-106.38M5%
Gain YTD-48.149-57.40784%
P/E RatioN/AN/A-
Revenue3.42M3.41M100%
Total Cash4.98M214M2%
Total Debt5.06M11.1M46%
FUNDAMENTALS RATINGS
DYAI: Fundamental Ratings
DYAI
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYAIQSI
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LDSVF15000.00150.00
+1.01%
Lindt & Sprungli AG
ARKAF70.18N/A
N/A
Arkema
SOBS29.10N/A
N/A
Solvay Bank (NY)
HKBNF0.40N/A
N/A
HKBN Ltd
PAIYY0.13N/A
N/A
Aesthetic Medical International Holdings Group Ltd.

DYAI and

Correlation & Price change

A.I.dvisor tells us that DYAI and MDGL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and MDGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
-2.53%
MDGL - DYAI
29%
Poorly correlated
+2.85%
FATE - DYAI
28%
Poorly correlated
-3.57%
TAOX - DYAI
27%
Poorly correlated
-5.42%
QSI - DYAI
25%
Poorly correlated
-0.86%
AUPH - DYAI
24%
Poorly correlated
-0.25%
More

QSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, QSI has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QSI
1D Price
Change %
QSI100%
-0.86%
AXON - QSI
49%
Loosely correlated
+1.59%
VCYT - QSI
47%
Loosely correlated
+4.68%
NNOX - QSI
45%
Loosely correlated
-1.52%
MESO - QSI
39%
Loosely correlated
-1.05%
ARRY - QSI
39%
Loosely correlated
+0.89%
More